Qualcomm reported fiscal fourth-quarter results on Wednesday that beat analyst estimates on the top and bottom lines.Here's how the company did, compared with estimates from analysts polled by LSEG:Earnings per share: $3.00 adjusted vs. $2.88 expectedRevenue: $11.27 billion vs. $10.79 billion expectedRevenue rose 10% from $10.24 billion a year earlier, Qualcomm said in a statement. Due to an income tax expense, the company recorded a net loss of $3.12 billion, or $2.89 a share, after reporting net income a ...

Reported Q3 2025 Total Revenues of $148.4 Million, Driven by Continued FIRDAPSE® Growth, Strong AGAMREE® Uptake and Growth, and Continued Demand for FYCOMPA® Raising Full-Year 2025 Total Revenue Guidance to between $565 Million and $585 Million, Reflecting Better than Originally Forecasted Performance Recently Announced Share Repurchase Program of up to $200 Million, Signaling Confidence in Long-term Outlook Conference Call and Webcast to be Held on Thursday, November 6, 2025, at 8:30 AM ET CORAL GABLES, F ...

Q1 REVENUE OF $1.58B, INCREASED 17% Y/Y AND, ON A PRO FORMA BASIS, 19% Y/Y ADJUSTED FOR SALE OF AEROSPACE & DEFENSE BUSINESSQ1 GAAP GROSS MARGIN OF 36.6%, INCREASED 249 bps Y/Y; Q1 NON-GAAP GROSS MARGIN OF 38.7%, INCREASED 200 bps Y/YQ1 GAAP EPS OF $1.19, IMPROVED $1.23 Y/Y; Q1 NON-GAAP EPS OF $1.16, IMPROVED $0.49 Y/Y SAXONBURG, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR) (“Coherent,” “We,” or the “Company”), a global leader in photonics, announced financial results today for its fir ...

Second Quarter Financial Highlights: Increased Revenue by Over 20% Year Over Year to Approximately $66 MillionReported Net Income of Nearly $5 Million and Non-GAAP Net Income Approaching $9 MillionAchieved Gross Margin Greater than 30% Company to host conference call tomorrow, November 6th, at 10:00 am ET AYER, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- AMSC (Nasdaq: AMSC), a leading system provider of megawatt-scale power resiliency solutions that orchestrate the rhythm and harmony of power on the grid™ a ...

财务业绩摘要 - 2025年第三季度净收入为2610万美元，主要由MIPLYFFA的2240万美元净收入驱动，相比2024年同期的370万美元大幅增长[2][6] - 2025年第三季度每股基本及摊薄净亏损为0.01美元，相比2024年同期的0.69美元净亏损显著收窄[1][11] - 公司现金、现金等价物及证券总额为2.304亿美元，管理层认为现有财务资源足以支持其战略重点的执行，无需依赖资本市场[11] 核心产品商业进展 - 旗舰产品MIPLYFFA在第三季度收到8份处方注册表，自产品推出以来累计达137份，市场覆盖率达到66%的受保生命，符合公司预期[7] - 另一款产品OLPRUVA在第三季度收到1份处方注册表，累计达30份，市场覆盖率为81%，但公司决定缩减其销售和营销力度[7] - MIPLYFFA净收入受到医疗保险D部分回扣重新设计的影响，产生了120万美元的总额到净额调整[6] 研发管线与临床进展 - 治疗尼曼匹克病C型的arimoclomol（即MIPLYFFA）的上市授权申请已获欧洲药品管理局验证并正在审评中，且被指定为孤儿药[7] - 治疗血管性埃勒斯-当洛斯综合征的候选药物Celiprolol，在事件驱动的第三阶段DiSCOVER试验中第三季度新增5名患者，累计达44名，并有一例确认事件[7] - 在第三季度，公司向8名新员工授予了合计93,000股公司普通股的期权，作为入职激励[8][9] 学术交流与数据发布 - 显示MIPLYFFA对尼曼匹克病C型具有持续长期疗效的开放标签扩展数据已在同行评审期刊《分子遗传学与代谢》上发表[7] - MIPLYFFA的研究数据在多个国际会议上展示，包括国家尼曼匹克病基金会会议、国际先天性代谢错误大会等[7] - 一项预先指定的分析新数据显示，在关键双盲研究中服用安慰剂并随后在开放标签扩展阶段换用MIPLYFFA的患者，其年疾病进展速度出现下降[7]

BROOMFIELD, Colo., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Noodles & Company (Nasdaq: NDLS) today announced financial results for its third quarter ended September 30, 2025. Key highlights for the third quarter of 2025 versus the third quarter of 2024 include: Total revenue decreased 0.5% to $122.1 million from $122.8 million in the third quarter of 2024.Comparable restaurant sales increased 4.0% system-wide, comprised of a 4.0% increase at company-owned restaurants and a 4.3% increase at franchise restaurants.Ne ...

- Dosed first patients with dabogratinib in BEACH301 and SURF302; interim results from both studies expected in 2026 - - Expanded development of dabogratinib into low-grade upper tract urothelial carcinoma (LG-UTUC); IND cleared with U.S. FDA - - Cash, cash equivalents, and marketable securities of $274.9 million at Q3 2025; runway through at least 2027 - CARLSBAD, Calif., Nov. 5, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-ge ...

Conference Call and Webcast scheduled for tomorrow, November 6, 2025 at 10:00 am MTEAGLE, Idaho, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.17 for the third quarter of 2025. Pennant also reported adjusted diluted earnings per share of $0.30 for the quarter(1). Third Quarter Highlights Tota ...

FY2025 Guidance Refined to Reflect Market DynamicsNEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Interparfums, Inc. (NASDAQ GS: IPAR) today reported results for the third quarter and nine months ended September 30, 2025. Financial Highlights:($ in millions, except per share amounts)Three Months EndedSeptember 30,Nine Months EndedSeptember 30,20252024% Change20252024% Change<td style="max-width:34%; width:34%; min-width:34%;;border-top: solid black 1pt ; b ...

Contribution ex-TAC(1) Grows 12% Year-Over-Year Contribution ex-TAC(1) from CTV Grows 18%, or 25% excluding political, Year-Over-Year NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Magnite (NASDAQ: MGNI), the largest independent sell-side advertising company, today reported its results of operations for the quarter ended September 30, 2025. Q3 2025 Highlights: Revenue of $179.5 million, up 11% year-over-yearContribution ex-TAC(1) of $166.8 million, up 12% year-over-year (16% excluding political), exceeded gui ...